Similar articles

• Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.

  Kuntzer T, Carota A, Novy J, Cavassini M, Du Pasquier RA. Kuntzer T, et al. Neurology. 2011 Feb 22;76(8):757-8. doi: 10.1212/WNL.0b013e31820d6290. Neurology. 2011. PMID: 21339503 No abstract available.
• Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.

  Stein B, Bird SJ. Stein B, et al. J Clin Neuromuscul Dis. 2011 Mar;12(3):163-4. doi: 10.1097/CND.0b013e3181df2b3e. J Clin Neuromuscul Dis. 2011. PMID: 21321497 No abstract available.
• Rituximab for severe myasthenia gravis--experience from five patients.

  Lindberg C, Bokarewa M. Lindberg C, et al. Acta Neurol Scand. 2010 Oct;122(4):225-8. doi: 10.1111/j.1600-0404.2010.01345.x. Acta Neurol Scand. 2010. PMID: 20199513
• Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review.

  Nelson RP Jr, Pascuzzi RM, Kessler K, Walsh LE, Faught PP, Ramanuja S, Pescovitz MD, Loehrer PJ Sr. Nelson RP Jr, et al. J Clin Neuromuscul Dis. 2009 Jun;10(4):170-7. doi: 10.1097/CND.0b013e31819a8403. J Clin Neuromuscul Dis. 2009. PMID: 19494727 Review.
• Rituximab for myasthenia gravis: three case reports and review of the literature.

  Stieglbauer K, Topakian R, Schäffer V, Aichner FT. Stieglbauer K, et al. J Neurol Sci. 2009 May 15;280(1-2):120-2. doi: 10.1016/j.jns.2009.02.357. Epub 2009 Mar 9. J Neurol Sci. 2009. PMID: 19272616 Review.